{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:02:32Z","timestamp":1789124552053,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics in Chest Medicine"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.ccm.2023.09.002","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T09:09:24Z","timestamp":1697015364000},"page":"33-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Biomarkers in Sarcoidosis"],"prefix":"10.1016","volume":"45","author":[{"given":"Sophie C.","family":"van der Mark","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikaash W.S.","family":"Bajnath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcel","family":"Veltkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ccm.2023.09.002_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1164\/ajrccm.160.2.ats4-99","volume":"160","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12931-020-01409-w","article-title":"Immunoreactivity to metal and silica associates with sarcoidosis in Dutch patients","volume":"21","author":"Beijer","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.ccm.2023.09.002_bib3","first-page":"100906","article-title":"Sarcoidosis in a patient clinically diagnosed with silicosis; is silica associated sarcoidosis a new phenotype?","volume":"28","author":"Beijer","year":"2019","journal-title":"Respir Med Case Rep"},{"issue":"11","key":"10.1016\/j.ccm.2023.09.002_bib4","doi-asserted-by":"crossref","first-page":"3576","DOI":"10.1172\/JCI32401","article-title":"Identification of HLA-DR-bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis","volume":"117","author":"Wahlstr\u00f6m","year":"2007","journal-title":"Clin Invest"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1465-9921-11-161","article-title":"Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis","volume":"11","author":"Oswald-Richter","year":"2010","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib6","first-page":"983","article-title":"Immunohistochemical detection of potential microbial antigens in granulomas in the diagnosis of sarcoidosis","volume":"10","author":"Yamaguchi","year":"2021","journal-title":"J\u00a0Clin Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib7","doi-asserted-by":"crossref","first-page":"00486","DOI":"10.1183\/23120541.00486-2020","article-title":"Presence of Propionibacterium acnes in granulomas associates with a chronic disease course in Dutch sarcoidosis patients","volume":"7","author":"Beijer","year":"2021","journal-title":"ERJ Open Res"},{"issue":"10","key":"10.1016\/j.ccm.2023.09.002_bib8","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211572","article-title":"A\u00a0fungal antigenic driver for L\u00f6fgren's syndrome sarcoidosis","volume":"218","author":"Lim","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1067\/mcp.2001.113989","article-title":"Biomarkers and surrogate endpoints: preferred definitions and conceptual framework","volume":"69","year":"2001","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"10.1016\/j.ccm.2023.09.002_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0954-6111(97)90252-3","article-title":"Serum angiotensin converting enzyme does not correlate with radiographic stage at initial diagnosis of sarcoidosis","volume":"91","author":"Shorr","year":"1997","journal-title":"Respir Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib11","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0002-9343(75)90395-2","article-title":"Elevation of serum angiotensin-converting-enzyme (ACE) level in sarcoidosis","volume":"59","author":"Lieberman","year":"1975","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib12","first-page":"185","article-title":"Biochemical markers in sarcoidosis","volume":"24","author":"Selroos","year":"1986","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/j.ccm.2023.09.002_bib13","series-title":"Sarcoidosis (ERS Monograph)","first-page":"107","article-title":"Serum and imaging biomarkers","author":"Korenromp","year":"2022"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib14","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.rmed.2006.06.025","article-title":"ACE I\/D-corrected Z-scores to identify normal and elevated ACE activity in sarcoidosis","volume":"101","author":"Kruit","year":"2007","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.09.002_bib15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.rmed.2014.11.009","article-title":"ACE and sIL-2R correlate with lung function improvement in sarcoidosis during methotrexate therapy","volume":"109","author":"Vorselaars","year":"2015","journal-title":"Respir Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1164\/ajrccm.156.5.97-02050","article-title":"Sarcoidosis: TNF-alpha release from alveolar macrophages and serum level of sIL-2R are prognostic markers","volume":"156","author":"Ziegenhagen","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.ccm.2023.09.002_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/17476348.2020.1751614","article-title":"Value of serum soluble interleukin-2 receptor as a diagnostic and predictive biomarker in sarcoidosis","volume":"14","author":"Schimmelpennink","year":"2020","journal-title":"Expert Rev Respir Med"},{"key":"10.1016\/j.ccm.2023.09.002_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1080\/1744666X.2016.1196135","article-title":"Biomarkers in sarcoidosis","volume":"12","author":"Chopra","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.4103\/0975-7406.106559","article-title":"Chitinases: an update","volume":"5","author":"Hamid","year":"2013","journal-title":"J\u00a0Pharm BioAllied Sci"},{"key":"10.1016\/j.ccm.2023.09.002_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1875044301205010001","article-title":"Role of chitotriosidase (chitinase 1) under normal and disease conditions","volume":"5","author":"Kanneganti","year":"2012","journal-title":"J\u00a0Epithel Biol Pharmacol"},{"issue":"4","key":"10.1016\/j.ccm.2023.09.002_bib21","first-page":"390","article-title":"Verifying sarcoidosis activity: chitotriosidase versus ACE in sarcoidosis - a case-control study","volume":"35","author":"Popevi\u0107","year":"2016","journal-title":"J\u00a0Med Biochem"},{"key":"10.1016\/j.ccm.2023.09.002_bib22","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00408-019-00219-2","article-title":"Identification of active sarcoidosis using chitotriosidase and angiotensin-converting enzyme","volume":"197","author":"Lopes","year":"2019","journal-title":"Lung"},{"key":"10.1016\/j.ccm.2023.09.002_bib23","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12931-019-1263-z","article-title":"Chitotriosidase: a biomarker of activity and severity in patients with sarcoidosis","volume":"21","author":"Bennett","year":"2020","journal-title":"Respir Res"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/PL00007637","article-title":"Serum lysozyme levels and clinical features of sarcoidosis","volume":"177","author":"Tomita","year":"1999","journal-title":"Lung"},{"issue":"7","key":"10.1016\/j.ccm.2023.09.002_bib25","first-page":"481","article-title":"Serum lysozyme concentration in silicosis patients and workers exposed to silica dust","volume":"65","author":"Koskinen","year":"1984","journal-title":"Eur J Respir Dis"},{"issue":"8","key":"10.1016\/j.ccm.2023.09.002_bib26","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00011-003-1181-9","article-title":"Potential role of immune system activation-associated production of neopterin derivatives in humans","volume":"52","author":"Hoffmann","year":"2003","journal-title":"Inflamm Res"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib27","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1183\/09031936.03.00010403","article-title":"Bronchoalveolar and serological parameters reflecting the severity of sarcoidosis","volume":"21","author":"Ziegenhagen","year":"2003","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2023.09.002_bib28","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s00408-014-9647-9","article-title":"Evaluation of circulating YKL-40 levels in idiopathic interstitial pneumonias","volume":"192","author":"Korthagen","year":"2014","journal-title":"Lung"},{"issue":"4","key":"10.1016\/j.ccm.2023.09.002_bib29","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.rmed.2004.09.016","article-title":"Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity?","volume":"99","author":"Johansen","year":"2005","journal-title":"Respir Med"},{"key":"10.1016\/j.ccm.2023.09.002_bib30","doi-asserted-by":"crossref","first-page":"2320","DOI":"10.1002\/eji.1830230940","article-title":"A\u00a0new macrophage differentiation antigen which is a member of the scavenger receptor superfamily","volume":"23","author":"Law","year":"1993","journal-title":"Eur J Immunol"},{"issue":"2","key":"10.1016\/j.ccm.2023.09.002_bib31","first-page":"99","article-title":"Serum levels of soluble CD163 as a specific marker of macrophage\/monocyte activity in sarcoidosis patients","volume":"32","author":"Tanimura","year":"2015","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"issue":"1\u20132","key":"10.1016\/j.ccm.2023.09.002_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.cca.2009.09.034","article-title":"Plasma chitotriosidase and CCL18 as surrogate markers for granulomatous macrophages in sarcoidosis","volume":"411","author":"Boot","year":"2010","journal-title":"Clin Chim Acta"},{"issue":"7","key":"10.1016\/j.ccm.2023.09.002_bib33","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1164\/rccm.200509-1518OC","article-title":"A\u00a0vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18","volume":"173","author":"Prasse","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib34","doi-asserted-by":"crossref","first-page":"43","DOI":"10.51620\/0869-2084-2022-67-1-43-47","article-title":"Analysis of rheumatoid factor and acute phase proteins using microarrays in patients with rheumatoid arthritis","volume":"67","author":"Feyzkhanova","year":"2022","journal-title":"Klin Lab Diagn"},{"key":"10.1016\/j.ccm.2023.09.002_bib35","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3389\/fmed.2019.00251","article-title":"Biomarkers reliably predicts Endoscopic disease activity in inflammatory bowel disease","volume":"6","author":"Bourgonje","year":"2019","journal-title":"Front Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.09.002_bib36","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1159\/000481269","volume":"46","author":"Saulnier","year":"2017","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.ccm.2023.09.002_bib37","doi-asserted-by":"crossref","first-page":"108784","DOI":"10.1016\/j.intimp.2022.108784","article-title":"Serum amyloid A\/anti-CCL20 induced the rebalance of Th17\/regulatory T cells in SodA-induced sarcoidosis","volume":"109","author":"Meng","year":"2022","journal-title":"Int Immunopharmacol"},{"issue":"11","key":"10.1016\/j.ccm.2023.09.002_bib38","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.7150\/ijms.18838","article-title":"Extensively disturbance of regulatory T cells - Th17 cells balance in stage II pulmonary sarcoidosis","volume":"14","author":"Ding","year":"2017","journal-title":"Int J Med Sci"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib39","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.rmed.2010.12.010","article-title":"Analysis of serum amyloid A in sarcoidosis patients","volume":"105","author":"Bargagli","year":"2011","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.ccm.2023.09.002_bib40","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1055\/s-0037-1603087","article-title":"Etiology and Immunopathogenesis of sarcoidosis: Novel Insights","volume":"38","author":"Beijer","year":"2017","journal-title":"Semin Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib41","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3390\/cells10030585","article-title":"Elevated serum amyloid a levels are not specific for sarcoidosis but associate with a fibrotic pulmonary phenotype","volume":"10","author":"Beijer","year":"2021","journal-title":"Cells"},{"issue":"7","key":"10.1016\/j.ccm.2023.09.002_bib42","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2003.tb00424.x","article-title":"Circulating CD14+ CD16+ monocytes are expanded in sarcoidosis patients","volume":"30","author":"Okamoto","year":"2003","journal-title":"J\u00a0Dermatol (Tokyo)"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib43","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1378\/chest.08-0443","article-title":"Increased expression of CD16, CD69, and very late antigen-1 on blood monocytes in active sarcoidosis","volume":"134","author":"Heron","year":"2008","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.09.002_bib44","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1183\/13993003.00709-2016","article-title":"Can intermediate monocytes predict response to infliximab therapy in sarcoidosis?","volume":"48","author":"Hijdra","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ccm.2023.09.002_bib45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1365-2249.1998.00617.x","article-title":"Selective depletion of CD14+CD16+ monocytes by glucocorticoid therapy","volume":"112","author":"Fingerle-Rowson","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ccm.2023.09.002_bib46","first-page":"65","article-title":"The integral role of b cells in sarcoidosis progression","author":"Pavuluri","year":"2021","journal-title":"EC Pulmonology and Respiratory Medicine"},{"key":"10.1016\/j.ccm.2023.09.002_bib47","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.ccm.2023.09.002_bib48","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1093\/rheumatology\/ket186","article-title":"Elevated serum BAFF levels in patients with sarcoidosis: association with disease activity","volume":"52","author":"Ueda-Hayakawa","year":"2013","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib49","doi-asserted-by":"crossref","first-page":"102462","DOI":"10.1016\/j.autrev.2020.102462","article-title":"Immune response biomarkers as indicators of sarcoidosis presence, prognosis, and possible treatment: an Immunopathogenic perspective","volume":"19","author":"Tarasidis","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.ccm.2023.09.002_bib50","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/ni833","article-title":"B\u00a0cells regulate autoimmunity by provision of IL-10","volume":"3","author":"Fillatreau","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/j.ccm.2023.09.002_bib51","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.ccm.2023.09.002_bib52","doi-asserted-by":"crossref","first-page":"e43588","DOI":"10.1371\/journal.pone.0043588","article-title":"Active chronic sarcoidosis is characterized by increased transitional blood B cells, increased IL-10-producing regulatory B cells and high BAFF levels","volume":"7","author":"Saussine","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ccm.2023.09.002_bib53","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","article-title":"Biomarkers in the diagnosis and prognosis of sarcoidosis: current Use and future Prospects","volume":"11","author":"Kraaijvanger","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.ccm.2023.09.002_bib54","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.1164\/ajrccm.164.10.2104046","article-title":"Clinical characteristics of patients in a case control study of sarcoidosis","volume":"164","author":"Baughman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ccm.2023.09.002_bib55","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation","volume":"2","author":"Scadding","year":"1961","journal-title":"Br Med J"},{"key":"10.1016\/j.ccm.2023.09.002_bib56","doi-asserted-by":"crossref","first-page":"600","DOI":"10.12688\/f1000research.11068.1","article-title":"Is it time to scrap Scadding and adopt computed tomography for initial evaluation of sarcoidosis?","volume":"7","author":"Levy","year":"2018","journal-title":"F1000Research"},{"key":"10.1016\/j.ccm.2023.09.002_bib57","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1378\/chest.08-1876","article-title":"Changes in chest roentgenogram of sarcoidosis patients during a clinical trial of infliximab therapy: comparison of different methods of evaluation","volume":"136","author":"Baughman","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ccm.2023.09.002_bib58","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1136\/thoraxjnl-2016-208833","article-title":"CTAS: a CT score to quantify disease activity in pulmonary sarcoidosis","volume":"71","author":"Benamore","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2023.09.002_bib59","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S2213-2600(13)70276-5","article-title":"An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study","volume":"2","author":"Walsh","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2023.09.002_bib60","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.lungcan.2017.10.015","article-title":"Radiomics and radiogenomics in lung cancer: a review for the clinician","volume":"115","author":"Thawani","year":"2018","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ccm.2023.09.002_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207959","article-title":"Quantitative image analysis using chest computed tomography in the evaluation of lymph node involvement in pulmonary sarcoidosis and tuberculosis","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib62","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1183\/09031936.00227014","article-title":"Effectiveness of infliximab in refractory FDG PET-positive sarcoidosis","volume":"46","author":"Vorselaars","year":"2015","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.ccm.2023.09.002_bib63","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/j.jcmg.2020.11.016","article-title":"Pre-treatment Myocardial 18FDG uptake predicts response to immunosuppression in patients with cardiac sarcoidosis","volume":"14","author":"Subramanian","year":"2021","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.ccm.2023.09.002_bib64","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2147\/OPTH.S264595","article-title":"Usefulness of combined measurement of serum soluble IL-2R and angiotensin-converting enzyme in the detection of uveitis associated with Japanese sarcoidosis","volume":"14","author":"Ishihara","year":"2020","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ccm.2023.09.002_bib65","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.cca.2019.10.010","article-title":"Combined application of angiotensin converting enzyme and chitotriosidase analysis improves the laboratory diagnosis of sarcoidosis","volume":"500","author":"Enyedi","year":"2020","journal-title":"Clin Chim Acta"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib66","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1465-9921-11-25","article-title":"Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients","volume":"11","author":"Grunewald","year":"2010","journal-title":"Respir Res"},{"issue":"4","key":"10.1016\/j.ccm.2023.09.002_bib67","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1164\/rccm.200807-1082OC","article-title":"L\u00f6fgren's syndrome: human leukocyte antigen strongly influences the disease course","volume":"179","author":"Grunewald","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib68","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1399-0039.1983.tb01192.x","article-title":"HLA-B8\/DR3 in sarcoidosis. Correlation to acute onset disease with arthritis","volume":"22","author":"Hedfors","year":"1983","journal-title":"Tissue Antigens"},{"issue":"4","key":"10.1016\/j.ccm.2023.09.002_bib69","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/thx.36.4.296","article-title":"Association of HLA B8 with spontaneous resolution in sarcoidosis","volume":"36","author":"Smith","year":"1981","journal-title":"Thorax"},{"key":"10.1016\/j.ccm.2023.09.002_bib70","doi-asserted-by":"crossref","unstructured":"Sato H, Grutters JC, Pantelidis P, et\u00a0al. HLA-DQB1\u22170201: a marker for good prognosis in British and Dutch patients with sarcoidosis. Am J Respir Cell Mol Biol. 2002;27(4):406-412.","DOI":"10.1165\/rcmb.4782"},{"key":"10.1016\/j.ccm.2023.09.002_bib71","doi-asserted-by":"crossref","unstructured":"Berlin M, Fogdell-Hahn A, Olerup O, et\u00a0al. HLA-DR predicts the prognosis in Scandinavian patients with pulmonary sarcoidosis. Am J Respir Crit Care Med. 1997;156(5):1601-1605.","DOI":"10.1164\/ajrccm.156.5.9704069"},{"issue":"6","key":"10.1016\/j.ccm.2023.09.002_bib72","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1164\/rccm.200303-459OC","article-title":"Human leukocyte antigen class I alleles and the disease course in sarcoidosis patients","volume":"169","author":"Grunewald","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.ccm.2023.09.002_bib73","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/cei.13257","article-title":"Bronchoalveolar lavage characteristics correlate with HLA tag SNPs in patients with L\u00f6fgren's syndrome and other sarcoidosis","volume":"196","author":"Karakaya","year":"2019","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib74","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1378\/chest.14-0781","article-title":"Breathomics in lung disease","volume":"147","author":"van der Schee","year":"2015","journal-title":"Chest"},{"issue":"7","key":"10.1016\/j.ccm.2023.09.002_bib75","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1111\/cea.12052","article-title":"Exhaled breath analysis by electronic nose in airways disease. Established issues and key questions","volume":"43","author":"Fens","year":"2013","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib76","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.chest.2021.10.025","article-title":"Diagnostic performance of electronic nose technology in sarcoidosis","volume":"161","author":"van der Sar","year":"2022","journal-title":"Chest"},{"issue":"3\u20134","key":"10.1016\/j.ccm.2023.09.002_bib77","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000083539","article-title":"Defining the phenotype in human genetic studies: forward genetics and reverse phenotyping","volume":"58","author":"Schulze","year":"2004","journal-title":"Hum Hered"},{"issue":"10","key":"10.1016\/j.ccm.2023.09.002_bib78","first-page":"218","article-title":"CD4+ T cells in the lungs of acute sarcoidosis patients recognize an Aspergillus nidulans epitope","author":"Greaves","year":"2021","journal-title":"J\u00a0Exp Med"},{"issue":"9030","key":"10.1016\/j.ccm.2023.09.002_bib79","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0140-6736(05)65205-1","article-title":"Mycobacteria and sarcoidosis","volume":"348","author":"Mitchell","year":"1996","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib80","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s10875-012-9700-5","article-title":"Dual analysis for mycobacteria and propionibacteria in sarcoidosis BAL","volume":"32","author":"Oswald-Richter","year":"2012","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib81","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1084\/jem.20040429","article-title":"Mycobacterial catalase-peroxidase is a tissue antigen and target of the adaptive immune response in systemic sarcoidosis","volume":"201","author":"Song","year":"2005","journal-title":"J\u00a0Exp Med"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib82","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.chest.2020.12.027","article-title":"Phase II investigation of the efficacy of antimycobacterial therapy in chronic pulmonary sarcoidosis","volume":"159","author":"Drake","year":"2021","journal-title":"Chest"},{"issue":"8","key":"10.1016\/j.ccm.2023.09.002_bib83","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.3390\/microorganisms10081649","article-title":"The role of cutibacterium acnes in sarcoidosis: from antigen to treatable trait?","volume":"10","author":"Kraaijvanger","year":"2022","journal-title":"Microorganisms"},{"key":"10.1016\/j.ccm.2023.09.002_bib84","unstructured":"Clinical trials.org. Latest updated December, 13, 2022. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05291468. Accessed January, 12, 2023."},{"issue":"2","key":"10.1016\/j.ccm.2023.09.002_bib85","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.clim.2009.04.010","article-title":"Hypothesis: sarcoidosis is a STAT1-mediated disease","volume":"132","author":"Rosenbaum","year":"2009","journal-title":"Clin Immunol"},{"issue":"26","key":"10.1016\/j.ccm.2023.09.002_bib86","doi-asserted-by":"crossref","first-page":"2540","DOI":"10.1056\/NEJMoa1805958","article-title":"Tofacitinib treatment and molecular analysis of cutaneous sarcoidosis","volume":"379","author":"Damsky","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.ccm.2023.09.002_bib87","doi-asserted-by":"crossref","first-page":"1801482","DOI":"10.1183\/13993003.01482-2018","article-title":"Dramatic response of refractory sarcoidosis under ruxolitinib in a patient with associated JAK2-mutated polycythemia","volume":"52","author":"Rotenberg","year":"2018","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.ccm.2023.09.002_bib88","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ni.3655","article-title":"Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression","volume":"18","author":"Linke","year":"2017","journal-title":"Nat Immunol"},{"issue":"12","key":"10.1016\/j.ccm.2023.09.002_bib89","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.3390\/cells10123545","article-title":"Activation of Downstream mTORC1 target Ribosomal protein S6 kinase (S6K) can Be found in a Subgroup of Dutch patients with granulomatous pulmonary disease","volume":"10","author":"Kraaijvanger","year":"2021","journal-title":"Cells"},{"issue":"10","key":"10.1016\/j.ccm.2023.09.002_bib90","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/17476348.2019.1655401","article-title":"New concepts in the pathogenesis of sarcoidosis","volume":"13","author":"Bennett","year":"2019","journal-title":"Expert Rev Respir Med"},{"issue":"1","key":"10.1016\/j.ccm.2023.09.002_bib91","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1183\/09031936.00002512","article-title":"Sarcoidosis-associated fatigue","volume":"40","author":"Drent","year":"2012","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.ccm.2023.09.002_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215763","article-title":"Scalp hair cortisol and testosterone levels in patients with sarcoidosis","volume":"14","author":"van Manen","year":"2019","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.ccm.2023.09.002_bib93","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.psyneuen.2011.09.009","article-title":"Hair cortisol as a biological marker of chronic stress: current status, future directions and unanswered questions","volume":"37","author":"Russell","year":"2012","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ccm.2023.09.002_bib94","article-title":"Online mindfulness-based cognitive therapy for fatigue in patients with sarcoidosis (TIRED): a randomised controlled trial [published online ahead of print, 2022 Nov 22]","author":"Kahlmann","year":"2022","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ccm.2023.09.002_bib95","unstructured":"Clinical trials.org. Latest updated January, 4, 2023 Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05314517. Accessed January 12, 2023."},{"key":"10.1016\/j.ccm.2023.09.002_bib96","unstructured":"Clinical trials.org. Latest updated December, 5, 2022 Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT05415137. Accessed January, 12, 2022."}],"container-title":["Clinics in Chest Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272523123000874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T01:18:25Z","timestamp":1759454305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272523123000874"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":96,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S0272523123000874"],"URL":"https:\/\/doi.org\/10.1016\/j.ccm.2023.09.002","relation":{},"ISSN":["0272-5231"],"issn-type":[{"value":"0272-5231","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers in Sarcoidosis","name":"articletitle","label":"Article Title"},{"value":"Clinics in Chest Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ccm.2023.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}